Ipsen announces change in R&D leadership: Howard Mayer to re

PARIS, FRANCE, 1 September 2023 – Ipsen ((Euronext: IPN, OTC:IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Christelle Huguet as Executive Vice President, Head of

Related Keywords

Switzerland , United States , Cambridge , Cambridgeshire , United Kingdom , Germany , Saclay , France General , France , Massachusetts , China , Shanghai , Paris , American , French , Christelle Huguet , David Loew , Howard Mayer , Institute Pasteur , Business Development , Inc Zebiai Therapeutics , Early Development , French University Diploma In Technology , Head Of Research , Pfizer , Leadership Team , Executive Vice President , Executive Leadership Team , Chief Executive Officer , Senior Vice President , External Innovation , Rare Disease , Executive Leadership , Chief Scientific Officer , X Chem Inc , Global Head , French University Diploma , European Engineering , Sponsored Level , American Depositary Receipt ,